Clinical trials
Phase 2/3 Lupus Erythematosus, Systemic trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
4 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2007 | 1 |
| 2022 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 1 |
| Completed | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 1 |
| Bristol-Myers Squibb | 1 |
| Genentech, Inc. | 1 |
| Paul R Fortin | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lupus Erythematosus, Systemic | 4 |
| Arthritis, Rheumatoid | 1 |
| Lupus Erythematosus, Cutaneous | 1 |
| Lupus Erythematosus, Discoid | 1 |
| Scleroderma, Diffuse | 1 |
| Scleroderma, Systemic | 1 |
| Systemic Vasculitis | 1 |
| Undifferentiated Connective Tissue Diseases | 1 |
Trials
Showing 1 to 4 of 4. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.